Cargando…

Higher Incidence of Diabetes in Cancer Patients Compared to Cancer-Free Population Controls: A Systematic Review and Meta-Analysis

SIMPLE SUMMARY: Diabetes increases the risk of certain types of cancer. However, the literature regarding the incidence of diabetes after cancer diagnosis is inconsistent. We aimed to assess whether there was a higher incidence of diabetes among cancer patients by performing a systematic review and...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Keyi, Liu, Zhunzhun, Thong, Melissa S. Y., Doege, Daniela, Arndt, Volker
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997959/
https://www.ncbi.nlm.nih.gov/pubmed/35406580
http://dx.doi.org/10.3390/cancers14071808
_version_ 1784684827944943616
author Yang, Keyi
Liu, Zhunzhun
Thong, Melissa S. Y.
Doege, Daniela
Arndt, Volker
author_facet Yang, Keyi
Liu, Zhunzhun
Thong, Melissa S. Y.
Doege, Daniela
Arndt, Volker
author_sort Yang, Keyi
collection PubMed
description SIMPLE SUMMARY: Diabetes increases the risk of certain types of cancer. However, the literature regarding the incidence of diabetes after cancer diagnosis is inconsistent. We aimed to assess whether there was a higher incidence of diabetes among cancer patients by performing a systematic review and meta-analysis of results from cohort studies. To the best of our knowledge, this review conducted the largest and most up-to-date meta-analysis to compare the incidence of diabetes between cancer patients and the cancer-free population. Our results suggest that new-onset diabetes is positively associated with cancer. ABSTRACT: Background: Diabetes increases the risk of certain types of cancer. However, the literature regarding the incidence of diabetes after cancer diagnosis is inconsistent. We aimed to assess whether there was a higher incidence of diabetes among cancer patients by performing a systematic review and meta-analysis of results from cohort studies. Methods: A systematic electronic literature search was carried out from cohort studies regarding the incidence of diabetes in cancer patients, using the databases PubMed (MEDLINE), Embase, Web of Science, and the Cochrane Library. Random-effects meta-analyses were conducted to pool the estimates. Results: A total of 34 articles involving 360,971 cancer patients and 1,819,451 cancer-free controls were included in the meta-analysis. An increased pooled relative risk (RR) of 1.42 (95% confidence interval (CI): 1.30–1.54, I(2) = 95, τ(2) = 0.0551, p < 0.01) for diabetes in cancer patients was found compared with the cancer-free population. The highest relative risk was observed in the first year after cancer diagnosis (RR = 2.06; 95% CI 1.63–2.60). Conclusions: New-onset diabetes is positively associated with cancer, but this association varies according to cancer type. More prospective studies with large sample sizes and longer follow-up times are advocated to further examine the association and the underlying mechanisms.
format Online
Article
Text
id pubmed-8997959
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-89979592022-04-12 Higher Incidence of Diabetes in Cancer Patients Compared to Cancer-Free Population Controls: A Systematic Review and Meta-Analysis Yang, Keyi Liu, Zhunzhun Thong, Melissa S. Y. Doege, Daniela Arndt, Volker Cancers (Basel) Systematic Review SIMPLE SUMMARY: Diabetes increases the risk of certain types of cancer. However, the literature regarding the incidence of diabetes after cancer diagnosis is inconsistent. We aimed to assess whether there was a higher incidence of diabetes among cancer patients by performing a systematic review and meta-analysis of results from cohort studies. To the best of our knowledge, this review conducted the largest and most up-to-date meta-analysis to compare the incidence of diabetes between cancer patients and the cancer-free population. Our results suggest that new-onset diabetes is positively associated with cancer. ABSTRACT: Background: Diabetes increases the risk of certain types of cancer. However, the literature regarding the incidence of diabetes after cancer diagnosis is inconsistent. We aimed to assess whether there was a higher incidence of diabetes among cancer patients by performing a systematic review and meta-analysis of results from cohort studies. Methods: A systematic electronic literature search was carried out from cohort studies regarding the incidence of diabetes in cancer patients, using the databases PubMed (MEDLINE), Embase, Web of Science, and the Cochrane Library. Random-effects meta-analyses were conducted to pool the estimates. Results: A total of 34 articles involving 360,971 cancer patients and 1,819,451 cancer-free controls were included in the meta-analysis. An increased pooled relative risk (RR) of 1.42 (95% confidence interval (CI): 1.30–1.54, I(2) = 95, τ(2) = 0.0551, p < 0.01) for diabetes in cancer patients was found compared with the cancer-free population. The highest relative risk was observed in the first year after cancer diagnosis (RR = 2.06; 95% CI 1.63–2.60). Conclusions: New-onset diabetes is positively associated with cancer, but this association varies according to cancer type. More prospective studies with large sample sizes and longer follow-up times are advocated to further examine the association and the underlying mechanisms. MDPI 2022-04-02 /pmc/articles/PMC8997959/ /pubmed/35406580 http://dx.doi.org/10.3390/cancers14071808 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Systematic Review
Yang, Keyi
Liu, Zhunzhun
Thong, Melissa S. Y.
Doege, Daniela
Arndt, Volker
Higher Incidence of Diabetes in Cancer Patients Compared to Cancer-Free Population Controls: A Systematic Review and Meta-Analysis
title Higher Incidence of Diabetes in Cancer Patients Compared to Cancer-Free Population Controls: A Systematic Review and Meta-Analysis
title_full Higher Incidence of Diabetes in Cancer Patients Compared to Cancer-Free Population Controls: A Systematic Review and Meta-Analysis
title_fullStr Higher Incidence of Diabetes in Cancer Patients Compared to Cancer-Free Population Controls: A Systematic Review and Meta-Analysis
title_full_unstemmed Higher Incidence of Diabetes in Cancer Patients Compared to Cancer-Free Population Controls: A Systematic Review and Meta-Analysis
title_short Higher Incidence of Diabetes in Cancer Patients Compared to Cancer-Free Population Controls: A Systematic Review and Meta-Analysis
title_sort higher incidence of diabetes in cancer patients compared to cancer-free population controls: a systematic review and meta-analysis
topic Systematic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997959/
https://www.ncbi.nlm.nih.gov/pubmed/35406580
http://dx.doi.org/10.3390/cancers14071808
work_keys_str_mv AT yangkeyi higherincidenceofdiabetesincancerpatientscomparedtocancerfreepopulationcontrolsasystematicreviewandmetaanalysis
AT liuzhunzhun higherincidenceofdiabetesincancerpatientscomparedtocancerfreepopulationcontrolsasystematicreviewandmetaanalysis
AT thongmelissasy higherincidenceofdiabetesincancerpatientscomparedtocancerfreepopulationcontrolsasystematicreviewandmetaanalysis
AT doegedaniela higherincidenceofdiabetesincancerpatientscomparedtocancerfreepopulationcontrolsasystematicreviewandmetaanalysis
AT arndtvolker higherincidenceofdiabetesincancerpatientscomparedtocancerfreepopulationcontrolsasystematicreviewandmetaanalysis